BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6982713)

  • 1. Pyrrolopyrimidine lethality in relation to ribonucleic acid synthesis in sarcoma 180 cells in vitro.
    Ritch PS; Helmsworth M
    Biochem Pharmacol; 1982 Aug; 31(16):2686-8. PubMed ID: 6982713
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.
    Ritch PS; Glazer RI
    Biochem Pharmacol; 1982 Jan; 31(2):259-61. PubMed ID: 7059368
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
    Glazer RI; Hartman KD; Cohen OJ
    Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
    Glazer RI; Peale AL
    Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dimethyl sulfoxide on RNA synthesis in S-180 tumor cells.
    Hagemann RF
    Experientia; 1969 Dec; 25(12):1298-300. PubMed ID: 5365866
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in RNA synthesis following transfer of Sarcoma 180 ascites cells from the mouse to synthetic medium.
    Watson JD; Ralph RK
    Cancer Res; 1966 Nov; 26(11):2362-7. PubMed ID: 5956639
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chelating agents upon the synthesis of nucleic acids and protein: inhibition of DNA synthesis by 1-formylisoquinoline thiosemicarbazone.
    Sartorelli AC
    Biochem Biophys Res Commun; 1967 Apr; 27(1):26-32. PubMed ID: 6048237
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake of uridine and its incorporation in RNA of Sarcoma 180 ascites tumour cells following in vivo gamma radiation and mitomycin C treatment.
    Karuri A; Mukherji S
    Indian J Biochem Biophys; 1987 Dec; 24(6):296-300. PubMed ID: 3133304
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation by 2'-deoxycoformycin of the inhibitory effect of xylosyladenine on nuclear RNA synthesis in L1210 cells in vitro.
    Peale AL; Glazer RI
    Biochem Pharmacol; 1978; 27(21):2543-7. PubMed ID: 728208
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.
    Creasey WA
    Biochem Pharmacol; 1969 Jan; 18(1):227-32. PubMed ID: 5780988
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS; Glazer RI; Cunningham RE; Shackney SE
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the polyadenylic acid segment associated with messenger ribonucleic acid in mouse sarcoma 180 ascites cells.
    Mendecki J; Lee SY; Brawerman G
    Biochemistry; 1972 Feb; 11(5):792-8. PubMed ID: 4536742
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of interleukin-2 messenger RNA in mouse lymphocytes by 2'-deoxycoformycin and adenosine metabolites.
    Cohen MB; Glazer RI
    Ann N Y Acad Sci; 1985; 451():180-7. PubMed ID: 3878116
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of possible relation of defects in purine metabolism to immune deficiency.
    Seegmiller JE
    Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Silvestrini R; Lenaz L; Di Fronzo G; Sanfilippo O
    Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
    Saffer JD; Glazer RI
    Mol Pharmacol; 1981 Jul; 20(1):211-7. PubMed ID: 7290086
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-Deoxycoformycin inhibition of intracellular phosphorylation of adenosine in Novikoff rat hepatoma cells.
    Plagemann PG; Wohlhueter RM
    Biochem Pharmacol; 1981 Mar; 30(5):417-26. PubMed ID: 6971643
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.